ADAR2-repressed RNA editing: a novel mechanism contributing to t (8:21) AML leukemogenesis
M. Guo, T. H. M. Chan, O. An, Y. Song, Z. H. Tan, V. H. E. Ng, X. Cao, W. J. Chng, M. Osato, H. Yang, Q. Zhou, L. Chen, D. G. Tenen
This study identifies ADAR2 downregulation in t(8;21) AML and shows its role in suppressing leukemogenesis through RNA editing.
bioRxiv · Oct 18, 2021 · PreprintCancer Biology